CTOs on the Move

Spero Health

www.sperohealth.com

 
When it comes to treating addiction to opioids and other substances, there`s no single magic bullet. Rather, it takes a combination of tools to surround patients with care and keep them on the road to recovery. Spero Health delivers outpatient care to treat patients close to home in their own environments so they can cope with life as they overcome addiction. We create an individualized treatment plan for each patient using a pioneering, proven, three-pronged approach: 1. Evidence-based physician services • Physician visit • Mental and physical health screenings • Individualized recovery plan • Medication-assisted treatment, which may include Suboxone® ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Edward Littlejohn
Chief Operating Officer Profile

Similar Companies

Visual Sonics

Visual Sonics is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LiveData

LiveData is a leading innovator of real-time data integration and display technology.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

RadiaShield

RadiaShield is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bonutti Clinic

Bonutti Clinic is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.